Jun 19, 2024, 09:28
Rafael Fonseca: Longer use of daratumumab results in better outcomes
Rafael Fonseca recently shared a post on X:
“Long term CASSIOPEIA shows what was expected – longer use of daratumumab results in better outcomes. 2×2 design (love these) allows this conclusion.”
Source: Rafael Fonseca/X
Dr. Rafael Fonseca, MD, is a hematologist at Mayo Clinic, specializing in multiple myeloma and related conditions.. Dr. Fonseca’s expertise extends to diagnosing and treating plasma cell disorders, leading clinical trials that have advanced myeloma treatment.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 16:51
Nov 13, 2024, 16:49
Nov 13, 2024, 16:45
Nov 13, 2024, 16:25
Nov 13, 2024, 16:23
Nov 13, 2024, 16:08
Nov 13, 2024, 16:02
Nov 13, 2024, 15:56